Insights from the ADC Symposium 2026
The ADC Symposium 2026, held in Prague on 16–17 September and organised by TKS event organiser, publisher of Chemistry Today, brought together experts from across the antibody-drug conjugate (ADC) field.
During the on-site event, the Chemistry Today team interviewed selected speakers and industry experts to explore some of the key challenges, developments and opportunities shaping ADC development and manufacturing.
Johanna Midelet
In this interview, Johanna Midelet from Abzena discusses the importance of anticipating manufacturing challenges from the earliest stages of ADC development, highlighting how innovative solutions and early planning can help support the transition from molecule design to clinical development and manufacturing.
The discussion also emphasises the value of collaboration and knowledge sharing across the ADC community, with scientific events such as the ADC Symposium providing opportunities to exchange ideas, explore emerging technologies and identify ways to accelerate development.
Looking ahead, Johanna explores the growing potential of next-generation ADCs, including novel payloads, bispecific constructs and dual-payload conjugates. While these increasingly complex molecules introduce new challenges in conjugation, analytical characterisation and manufacturing, they also represent exciting opportunities for innovation and the future evolution of the ADC field.
For more information on the ADC Symposium visit the official event website: Home – ADC
